Mellaril Patient, Information, Instructions - Thioridazine HCl

Mellaril Patient, Information, Instructions - Thioridazine HCl

PATIENT INFORMATION

Patients should be informed that Mellaril has been associated with potentially fatal heart rhythm disturbances. The risk of such events may be increased when certain drugs are given together with Mellaril. Therefore, patients should inform the prescriber that they are receiving Mellaril treatment before taking any new medication.

Given the likelihood that some patients exposed chronically to neuroleptics will develop tardive dyskinesia, it is advised that all patients in whom chronic use is contemplated be given, if possible, full information about this risk. The decision to inform patients and/or their guardians must obviously take into account the clinical circumstances and the competency of the patient to understand the information provided.